跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 686 条关于
“Perjeta (pertuzumab)”
全部
686
临床试验
542
药物
48
机构
0
资讯
96
去年
Henlius and Organon's HLX11 Biosimilar Meets Primary Endpoint in Phase 3 Breast Cancer Trial
10个月前
FDA Approves First Perjeta Biosimilar as Shanghai Henlius and Organon Secure Interchangeable Status
5年前
EMA Committee Backs Roche's Phesgo, A Novel Subcutaneous Combination of Herceptin and Perjeta for HER2+ Breast Cancer
12个月前
Alkem Laboratories Launches Affordable Pertuzumab Biosimilar for HER2-Positive Breast Cancer in India
去年
Ten-Year APHINITY Data Shows Perjeta-Based Regimen Reduces Death Risk by 17% in HER2-Positive Early Breast Cancer
11个月前
Pfizer's Tukysa Shows Positive Results in Phase III Maintenance Trial for HER2-Positive Breast Cancer
上个月
Roche Canada and pCPA Complete Negotiations for Perjeta in Neoadjuvant HER2-Positive Early Breast Cancer
2年前
Delhi High Court Bans Zydus' Pertuzumab Biosimilar Sigrima in Patent Infringement Case
去年
Genentech Initiates First Patent Litigation Against Pertuzumab Biosimilar HLX11
去年
Trastuzumab Biosimilar Plus Pertuzumab Shows Efficacy in HER2-Positive Breast Cancer
第 1 页,共 10 页
上一页
下一页